IDEX Biometrics ASA
IDXAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $137 | $72,087 | $156,015 | $666,633 |
| - Cash | $2,006 | $11,388 | $16,124 | $33,827 |
| + Debt | $3,023 | $6,960 | $11,652 | $410 |
| Enterprise Value | $1,154 | $67,659 | $151,543 | $633,216 |
| Revenue | $794 | $4,152 | $4,092 | $2,840 |
| % Growth | -80.9% | 1.5% | 44.1% | – |
| Gross Profit | -$11,482 | $232 | $848 | $1,586 |
| % Margin | -1,445.5% | 5.6% | 20.7% | 55.8% |
| EBITDA | -$9,106 | -$273,857 | -$29,921 | -$29,537 |
| % Margin | -1,146.4% | -6,595.7% | -731.2% | -1,040% |
| Net Income | -$13,647 | -$26,713 | -$32,660 | -$32,550 |
| % Margin | -1,718.1% | -643.4% | -798.1% | -1,146.1% |
| EPS Diluted | -1.75 | -55.857 | -76.37 | -76.964 |
| % Growth | 96.9% | 26.9% | 0.8% | – |
| Operating Cash Flow | -$17,534 | -$27,090 | -$31,897 | -$27,465 |
| Capital Expenditures | $16,432 | -$244 | -$267 | -$141 |
| Free Cash Flow | -$17,534 | -$27,334 | -$32,164 | -$27,606 |